Paul Manka
Impact in
- Hepatology top 1%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 37
- Liver Disease and Transplantation 26
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Liver Diseases and Immunity 6
- Liver physiology and pathology 5
- Hepatitis Viruses Studies and Epidemiology 5
- Epidemiology 44
- Liver Disease Diagnosis and Treatment 42
- Co-authors
- Ali CanbayGuido GerkenJan BestWing‐Kin SynLars P. BechmannAlişan KahramanJason D. CoombesJens Verheyen
- Journals
- Digestive Diseases (4 papers)Journal of Personalized Medicine (4 papers)Digestive Diseases and Sciences (4 papers)PLoS ONE (3 papers)Digestion (2 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Paul Manka
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Hepatology 621
- Epidemiology 695
- Pharmacology 132
- Endocrinology, Diabetes and Metabolism 123
- Cancer Research 95
Countries citing papers authored by Paul Manka
This map shows the geographic impact of Paul Manka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Manka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Manka more than expected).
Fields of papers citing papers by Paul Manka
This network shows the impact of papers produced by Paul Manka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Manka. The network helps show where Paul Manka may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Manka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 15 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | Non-Invasive Risk Stratification in NAFLD/NASH Patients for Screening EGD | 2022 | 1 |
| 12 | 2021 | 34 | |
| 13 | 2018 | 59 | |
| 14 | 2018 | 5 | |
| 15 | 2017 | 50 | |
| 16 | 2015 | 14 | |
| 17 | 2015 | 72 | |
| 18 | 2014 | 22 | |
| 19 | 2013 | 11 | |
| 20 | 2009 | 50 |
About Paul Manka
Paul Manka is a scholar working on Hepatology, Epidemiology, Pharmacology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (42 papers), Liver Disease and Transplantation (26 papers), Diet, Metabolism, and Disease (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Liver Diseases and Immunity (6 papers), Liver physiology and pathology (5 papers) and Hepatitis Viruses Studies and Epidemiology (5 papers). The work is most often cited by research in Hepatology (621 citations), Epidemiology (695 citations), Pharmacology (132 citations), Endocrinology, Diabetes and Metabolism (123 citations) and Cancer Research (95 citations). Paul Manka has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Ali Canbay, Guido Gerken, Jan Best, Wing‐Kin Syn, Lars P. Bechmann, Wing‐Kin Syn, Alişan Kahraman, Jason D. Coombes, Jens Verheyen and Matthias Buechter. Their work appears in journals such as Digestive Diseases, Journal of Personalized Medicine, Digestive Diseases and Sciences, PLoS ONE and Digestion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.